Search results
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Singapore Finance· 5 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Singapore Finance· 4 days agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
AbbVie cuts 2024 profit forecast on R&D expenses
Reuters via Yahoo Singapore Finance· 2 days ago(Reuters) -AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses...
2 Boston Partners Mutual Funds for Maximum Returns
Zacks via Yahoo Singapore Finance· 19 hours agoRamallo has been the lead manager of BPAVX since Dec 30, 2007. Most of the fund’s holdings were in companies like Johnson & Johnson (2.2%), JPMorgan...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Singapore Finance· 16 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
Company News for Jul 3, 2024
Zacks via Yahoo Singapore Finance· 3 days agoShares of Apple Inc. AAPL rose 1.6% on the continued mega-cap growth stock rally. iQIYI, Inc.’s IQ shares rose 1.4% on consumer discretionaries scoring a...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Singapore Finance· 3 days agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Singapore Finance· 4 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
